Javascript is required to run this page

HB342

Naloxone or other opioid antagonists; possession by state agencies, guidelines for private employer.

Status:
Enacted

Chief Patron:
Patrick Hope (D)

Session:
2024 Regular Session

Summary

As Passed Both Chambers. Naloxone or other opioid antagonists; possession and administration by state agencies.

Requires state agencies to possess naloxone or other opioid antagonists used for overdose reversal to a person who is believed to be experiencing or about to experience a life-threatening opioid overdose and permits employees of any state agency to possess and administer naloxone or other opioid antagonists. The bill also directs the Department of Health to post on its website informational resources relating to the use of naloxone and other opioid antagonists for opioid overdose reversal and prevention in public places. Finally, the bill directs the Department of Health to develop a plan for the procurement and distribution of naloxone or other opioid antagonists to each state agency and for the possession of naloxone or other opioid antagonists by each state agency and to report its progress in developing such plan to the Governor and the Chairmen of the House Committee on Health and Human Services and the Senate Committee on Education and Health by November 1, 2024. (Less)
  • Bill History

  • 01/05/2024 - House: Prefiled and ordered printed; offered 01/10/24 24100674D
  • 01/05/2024 - House: Referred to Committee on Health and Human Services
  • 01/17/2024 - House: Assigned sub: Health
  • 01/23/2024 - House: Impact statement from DPB (HB342)
  • 02/01/2024 - House: House subcommittee amendments and substitutes offered
  • 02/01/2024 - House: Subcommittee recommends reporting with substitute (8-Y 0-N)
  • 02/01/2024 - House: Subcommittee recommends referring to Committee on Appropriations
  • 02/06/2024 - House: Reported from Health and Human Services with substitute (22-Y 0-N)
  • 02/06/2024 - House: Committee substitute printed 24106801D-H1
  • 02/08/2024 - House: Read first time
  • 02/09/2024 - House: Impact statement from DPB (HB342H1)
  • 02/09/2024 - House: Read second time
  • 02/09/2024 - House: Committee substitute agreed to 24106801D-H1
  • 02/09/2024 - House: Engrossed by House - committee substitute HB342H1
  • 02/12/2024 - House: Read third time and passed House BLOCK VOTE (100-Y 0-N)
  • 02/12/2024 - House: VOTE: Block Vote Passage (100-Y 0-N)
  • 02/13/2024 - Senate: Constitutional reading dispensed
  • 02/13/2024 - Senate: Referred to Committee on Education and Health
  • 02/21/2024 - Senate: Assigned Education and Health Sub: Health Professions
  • 02/29/2024 - Senate: Reported from Education and Health (15-Y 0-N)
  • 02/29/2024 - Senate: Rereferred to Finance and Appropriations
  • 03/04/2024 - Senate: Reported from Finance and Appropriations with substitute (15-Y 0-N)
  • 03/04/2024 - Senate: Committee substitute printed 24108846D-S1
  • 03/05/2024 - Senate: Constitutional reading dispensed (39-Y 0-N)
  • 03/05/2024 - House: Impact statement from DPB (HB342S1)
  • 03/06/2024 - Senate: Read third time
  • 03/06/2024 - Senate: Reading of substitute waived
  • 03/06/2024 - Senate: Committee substitute agreed to 24108846D-S1
  • 03/06/2024 - Senate: Engrossed by Senate - committee substitute HB342S1
  • 03/06/2024 - Senate: Passed Senate with substitute (40-Y 0-N)
  • 03/07/2024 - House: Senate substitute rejected by House 24108846D-S1 (0-Y 99-N)
  • 03/07/2024 - House: VOTE: REJECTED (0-Y 99-N)
  • 03/07/2024 - Senate: Senate insisted on substitute (40-Y 0-N)
  • 03/07/2024 - Senate: Senate requested conference committee
  • 03/07/2024 - House: House acceded to request
  • 03/07/2024 - Senate: Conferees appointed by Senate
  • 03/07/2024 - Senate: Senators: Favola, Aird, Head
  • 03/07/2024 - House: Conferees appointed by House
  • 03/07/2024 - House: Delegates: Hope, Shin, Higgins
  • 03/08/2024 - Conference: Amended by conference committee
  • 03/08/2024 - House: Conference substitute printed 24109115D-H2
  • 03/08/2024 - Senate: Conference report agreed to by Senate (40-Y 0-N)
  • 03/08/2024 - House: Conference report agreed to by House (95-Y 0-N)
  • 03/08/2024 - House: VOTE: Adoption (95-Y 0-N)
  • 03/08/2024 - House: Impact statement from DPB (HB342H2)
  • 03/25/2024 - House: Enrolled
  • 03/25/2024 - House: Bill text as passed House and Senate (HB342ER)
  • 03/25/2024 - Senate: Signed by President
  • 03/26/2024 - House: Signed by Speaker
  • 03/27/2024 - House: Impact statement from DPB (HB342ER)
  • 03/27/2024 - House: Enrolled Bill communicated to Governor on March 27, 2024
  • 03/27/2024 - Governor: Governor's Action Deadline 11:59 p.m., April 8, 2024
  • 04/04/2024 - Governor: Approved by Governor-Chapter 440 (effective 7/1/24)
  • 04/04/2024 - Governor: Acts of Assembly Chapter text (CHAP0440)